A case of osimertinib-resistant lung adenocarcinoma responded effectively to alternating therapy

We report a case of initial lung adenocarcinoma in which transformation to small cell lung carcinoma (SCLC) was observed after acquired resistance to the 3(rd) generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) osimertinib and alternating treatment between chemotherapy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Transl Med
Main Authors: Hirakawa, Haruki, Komiya, Kazutoshi, Nakashima, Chiho, Ogusu, Shinske, Nakamura, Tomomi, Tanaka, Masahide, Takahashi, Koichiro, Egashira, Yoshiaki, Kai, Keita, Kimura, Shinya, Sueoka-Aragane, Naoko
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2018
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6312808/
https://ncbi.nlm.nih.gov/pubmed/30603652
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2018.11.25
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados